Evidence map›Paper›PMID 38169861›Full record

ArticleHeliyon2024

Improving hepatocellular carcinoma diagnosis using an ensemble classification approach based on Harris Hawks Optimization.

LiuRen Lin, YunKuan Liu, Min Gao, Amin Rezaeipanah

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

LiuRen LinDepartment of Pharmacy and Machinery, Qujing Second People's Hospital, Yunnan, Qujing, 655000, China.
YunKuan LiuYunnan University of Chinese Medicine, Yunnan Key Laboratory of External Drug Delivery System and Preparation Technology in Universities, Yunnan, Kunming, 650500, China.
Min GaoFaculty of Life Science and Technology, Kunming University of Science and Technology, Yunnan, Kunming, 650500, China.
Amin RezaeipanahDepartment of Computer Engineering, Persian Gulf University, Bushehr, Iran.
Kunming University of Science and Technology · CNPersian Gulf University · IRXian Yang Central Hospital · CNYunnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepato-Cellular Carcinoma (HCC) is the most common type of liver cancer that often occurs in people with chronic liver diseases such as cirrhosis. Although HCC is known as a fatal disease, early detection can lead to successful treatment and improve survival chances. In recent years, the development of computer recognition systems using machine learning approaches has been emphasized by researchers. The effective performance of these approaches for the diagnosis of HCC has been proven in a wide range of applications. With this motivation, this paper proposes a hybrid machine learning approach including effective feature selection and ensemble classification for HCC detection, which is developed based on the Harris Hawks Optimization (HHO) algorithm. The proposed ensemble classifier is based on the bagging technique and is configured based on the decision tree method. Meanwhile, HHO as an emerging meta-heuristic algorithm can select a subset of the most suitable features related to HCC for classification. In addition, the proposed method is equipped with several strategies for handling missing values and data normalization. The simulations are based on the HCC dataset collected by the Coimbra Hospital and University Center (CHUC). The results of the experiments prove the acceptable performance of the proposed method. Specifically, the proposed method with an accuracy of 97.13 % is superior in comparison with the equivalent methods such as LASSO and DTPSO.

Indexed as

Ensemble classificationFeature selectionHCCHHOMedical diagnosis system

Identifiers

PMID38169861
PMCPMC10758797
OpenAlexW4389510115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.